CNN has cranked up their anti-Trump spin machine.

The same so-called “mainstream” media outlet – which Trump has already pegged as a fake news network – is churning out negative story after negative story in their desperate attempt to destroy his Presidency.

CNN thought they had one of Trump’s nominees caught in a major scandal, but a closer examination of the evidence revealed some big holes in their story.

Donald Trump nominated former Georgia Congressman Tom Price to run the Department of Health and Human Services (HHS).

In this role, Price would be one of the point men on repealing Obamacare.

This made him public enemy #1 with the left.

So CNN obliged the Democrats by running negative stories to try and force Price to drop out.

Their hit piece centered on essentially accusing Price of trading insider information and accepting a bribe from a company who would benefit from a piece of legislation Price would introduce to stop Obamacare’s harmful impacts.

There is only one problem.

The story is just more of CNN’s fake news.

CNN claimed Price – who is worth more than ten million dollars – bought between $1,001 and $15,000 worth of stock in Zimmer Biomet in March of 2016.

After the stock purchase, he introduced the HIP Act, which would have stopped a harmful Obamacare regulation.

Zimmer Biomet then donated $1,000 to Price’s campaign.

CNN thought they had a Trump nominee dead to rights for using legislation to inflate the stock price of a company he invested in, and then accepting a campaign contribution from them hand over fist.

The story was quickly debunked.

Price’s former Press Secretary Ellen Carmichael explained that Price’s investments are managed by Morgan Stanley and he wasn’t even made aware of the stock purchase until April 4th, which was after he introduced his legislation to roll back Obamacare’s harmful effects.

Carmichael laid out the timeline in an Independent Journal Review op-ed where she also included the key detail that the HIP Act was something Price supported dating as far back to September of 2015:

“Dr. Price’s personal investment portfolio is managed by a Morgan Stanley financial adviser who directs all trade transactions conducted on his behalf. Pursuant to his agreement with the investment firm, he is not involved in the decision to buy or sell any stocks. His portfolio contains both health care and non-health care related stocks.

On March 17, 2016, his adviser conducted a periodic rebalancing of his portfolio. At this time, Morgan Stanley purchased 26 stocks of Zimmer Biomet, totaling $2,697.74, on behalf of Dr. Price, in addition to other financial products as a part of routine management.

Dr. Price first learned of the purchase of this stock on April 4, 2016, when he received notification of all trades to be disclosed on his House Periodic Transaction Report. On April 15, 2016, Dr. Price submitted a filing of all transactions, in accordance with federal laws and Congressional rules governing disclosure compliance.

The legislation to which CNN refers regarding Zimmer Biomet’s potential interest concerned a comprehensive joint replacement demonstration project. For many years, Dr. Price has expressed opposition to Obamacare and thus, he has an extensive record of communicating with various government agencies throughout his time in Congress on specific pieces of health care policy.

Dr. Price’s office points to a September 21, 2015 “Dear Colleague” letter he wrote and that was signed by dozens of other lawmakers indicating a desire to delay the project to preserve treatment options for patients. His public opposition to this project is well documented.”

CNN’s fact-free, fake news story designed to smear a key Trump nominee and damage the Republicans ability to repeal Obamacare was quickly debunked.

Nonsense stories like this are detached from reality, but carry a clear anti-Trump bias, which is why so many are quick to dismiss everything they read in the so-called “mainstream” media as fake news.

The last few months have proven very difficult to believe any negative stories published about Trump in the “mainstream” media because they are agenda driven hit pieces and usually end up to be fake news.